Published in J Immunol on March 01, 1982
Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 snRNPs in coiled bodies. J Cell Biol (1992) 4.57
Identification of a novel nuclear domain. J Cell Biol (1991) 3.91
The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A (1984) 3.51
Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machinery. EMBO J (1991) 3.49
In vitro assembly of U1 snRNPs. EMBO J (1987) 3.18
The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3' splice site. Proc Natl Acad Sci U S A (1992) 3.04
In vivo detection of snRNP-rich organelles in the nuclei of mammalian cells. EMBO J (1991) 2.90
Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs. Nucleic Acids Res (1988) 2.86
The human U1-70K snRNP protein: cDNA cloning, chromosomal localization, expression, alternative splicing and RNA-binding. Nucleic Acids Res (1987) 2.57
Direct, sequence-specific binding of the human U1-70K ribonucleoprotein antigen protein to loop I of U1 small nuclear RNA. Mol Cell Biol (1989) 2.29
Autoantibodies to ribonucleoprotein particles containing U2 small nuclear RNA. EMBO J (1985) 2.04
Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med (1994) 2.02
The Mr 70,000 protein of the U1 small nuclear ribonucleoprotein particle binds to the 5' stem-loop of U1 RNA and interacts with Sm domain proteins. Proc Natl Acad Sci U S A (1988) 1.98
Reconstitution of the U1 small nuclear ribonucleoprotein particle. Mol Cell Biol (1987) 1.94
Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals. EMBO J (1997) 1.85
Structure and expression of the Drosophila melanogaster gene for the U1 small nuclear ribonucleoprotein particle 70K protein. Mol Cell Biol (1990) 1.85
Identification of a functional mammalian spliceosome containing unspliced pre-mRNA. Proc Natl Acad Sci U S A (1988) 1.85
Loop I of U1 small nuclear RNA is the only essential RNA sequence for binding of specific U1 small nuclear ribonucleoprotein particle proteins. Mol Cell Biol (1988) 1.77
Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs. Nucleic Acids Res (1990) 1.68
Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis (1991) 1.68
WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc Natl Acad Sci U S A (1998) 1.64
Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol (1985) 1.62
Immunoelectron microscope visualization of nuclear ribonucleoprotein antigens within spread transcription complexes. J Cell Biol (1986) 1.62
Redistribution of nuclear ribonucleoprotein antigens during herpes simplex virus infection. J Cell Biol (1987) 1.61
A geminivirus replication protein is a sequence-specific DNA binding protein. Plant Cell (1992) 1.61
Multiple domains of U1 snRNA, including U1 specific protein binding sites, are required for splicing. EMBO J (1990) 1.60
U1 small nuclear ribonucleoprotein particle-specific proteins interact with the first and second stem-loops of U1 RNA, with the A protein binding directly to the RNA independently of the 70K and Sm proteins. Mol Cell Biol (1989) 1.56
A conserved epitope on a subset of SR proteins defines a larger family of Pre-mRNA splicing factors. J Cell Biol (1995) 1.51
Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes. Proc Natl Acad Sci U S A (1984) 1.50
Dynamic organization of splicing factors in adenovirus-infected cells. J Virol (1995) 1.48
Differential interaction of splicing snRNPs with coiled bodies and interchromatin granules during mitosis and assembly of daughter cell nuclei. J Cell Biol (1994) 1.44
Protein antigens of the RNA-protein complexes detected by anti-SM and anti-RNP antibodies found in serum of patients with systemic lupus erythematosus and related disorders. J Exp Med (1982) 1.38
IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. Immunology (1984) 1.37
Characterization of an epibody. An antiidiotype that reacts with both the idiotype of rheumatoid factors (RF) and the antigen recognized by RF. J Exp Med (1985) 1.32
Primary structure of a human arginine-rich nuclear protein that colocalizes with spliceosome components. Proc Natl Acad Sci U S A (1991) 1.29
Polypeptide components of human small nuclear ribonucleoproteins. Proc Natl Acad Sci U S A (1983) 1.23
Zinc finger-like structure in U1-specific protein C is essential for specific binding to U1 snRNP. Nucleic Acids Res (1991) 1.22
Nuclear matrins: identification of the major nuclear matrix proteins. Proc Natl Acad Sci U S A (1991) 1.20
The dynamics of coiled bodies in the nucleus of adenovirus-infected cells. Mol Biol Cell (1996) 1.16
Association of the neuron-specific RNA binding domain-containing protein ELAV with the coiled body in Drosophila neurons. Chromosoma (1997) 1.11
Nuclear exchange of the U1 and U2 snRNP-specific proteins. J Cell Biol (1990) 1.08
Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice. Arthritis Rheum (2002) 1.06
Nuclear organization of splicing snRNPs during differentiation of murine erythroleukemia cells in vitro. J Cell Biol (1993) 1.06
Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol (1990) 1.02
Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest (1996) 1.01
Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy. Arch Dermatol Res (1983) 1.01
Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J Exp Med (1990) 0.99
Members of a family of proteins (the RD family) detected by a U1 70K monoclonal antibody are present in spliceosomal complexes. Nucleic Acids Res (1995) 0.98
Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG. Clin Exp Immunol (1991) 0.97
MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. Immunology (1994) 0.96
Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death. J Exp Med (1998) 0.95
Multiple splicing factors are released from endogenous complexes during in vitro pre-mRNA splicing. Mol Cell Biol (1989) 0.94
Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins. Mol Cell Biol (2005) 0.92
Individual variation of anti-Sm autoantibodies in the MRL/MP-lpr/lpr mouse: age-related increase in diversity. Clin Exp Immunol (1986) 0.92
Distribution of splicing proteins and putative coiled bodies during pollen development and androgenesis in Brassica napus L. Protoplasma (2001) 0.91
A pre-export U1 snRNP in Xenopus laevis oocyte nuclei. Nucleic Acids Res (1993) 0.89
Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res Ther (2005) 0.89
Recombinant 70-kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol (1990) 0.88
Identification and characterization of the small nuclear ribonucleoprotein particle D' core protein. Mol Cell Biol (1990) 0.86
Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization. Clin Exp Immunol (1993) 0.84
Characterization and idiotypic analysis of an anti-RNP monoclonal antibody. Clin Exp Immunol (1984) 0.83
p75, a polypeptide component of karyoskeletal protein-enriched fractions associated with transcriptionally active loci of Drosophila melanogaster polytene chromosomes. Mol Cell Biol (1988) 0.83
Periodic expression of Sm proteins parallels formation of nuclear Cajal bodies and cytoplasmic snRNP-rich bodies. Histochem Cell Biol (2011) 0.82
Maintenance of autoantibody production in pristane-induced murine lupus. Arthritis Res Ther (2015) 0.82
Further characterization of the autoantibody response of Palmerston North mice. J Clin Immunol (1999) 0.78
Purification of antigens and monoclonal antibodies. Clin Rheumatol (1987) 0.75
Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc Natl Acad Sci U S A (1977) 6.80
Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc Natl Acad Sci U S A (1967) 6.05
Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family. Nature (1977) 4.31
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci U S A (1993) 4.11
Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med (1975) 3.13
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
The human U1-70K snRNP protein: cDNA cloning, chromosomal localization, expression, alternative splicing and RNA-binding. Nucleic Acids Res (1987) 2.57
Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med (1978) 2.52
Control of tryptophan biosynthesis by the methyltryptophan resistance gene in Bacillus subtilis. J Bacteriol (1971) 2.39
In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med (1978) 2.34
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med (1976) 2.34
Enzymes of the tryptophan operon of Bacillus subtilis. Biochem Biophys Res Commun (1969) 2.16
Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12
Molecular cloning of a cDNA encoding the human Sm-D autoantigen. Proc Natl Acad Sci U S A (1988) 2.08
Human serum lyses RNA tumour viruses. Nature (1975) 1.92
Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes. Biochem Biophys Res Commun (1981) 1.91
Characterization of U small nuclear RNA-associated proteins. J Biol Chem (1984) 1.81
Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sci U S A (1988) 1.79
Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Menière's disease. Laryngoscope (1995) 1.74
Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood (1985) 1.54
Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc Natl Acad Sci U S A (1978) 1.51
Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1987) 1.50
Differential expression of two distinct xenotropic viruses in NZB mice. Clin Immunol Immunopathol (1980) 1.48
Nuclear ribonucleoprotein complexes containing polyadenylate from mouse ascites cells. Proc Natl Acad Sci U S A (1974) 1.46
Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol (1985) 1.44
Identification of the immunogenically active components of the Sm and RNP antigens. Proc Natl Acad Sci U S A (1981) 1.43
Rescue of infectious SV40 after fusion between dfferent SV 40-transformed cells. Proc Natl Acad Sci U S A (1968) 1.43
Characterization of the autoantigen calreticulin. J Immunol (1991) 1.42
Isolation of intact Sm/RNP antigens from rabbit thymus. J Immunol (1983) 1.40
Barotrauma during jet ventilation for microlaryngeal surgery. Anaesthesia (1995) 1.39
Mapping of the 5-methyltryptophan resistance locus in Bacillus subtilis. J Bacteriol (1974) 1.35
Assays for the Sm and RNP autoantigens: the requirement for RNA and influence of the tissue source. J Immunol (1982) 1.34
Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats. J Immunol (1977) 1.31
Absence of repressor in SV40-transformed cells. Virology (1969) 1.30
Enzymes of the tryptophan pathway in three Bacillus species. J Bacteriol (1973) 1.30
Genetic differences at four DNA typing loci in Finnish, Italian, and mixed Caucasian populations. Proc Natl Acad Sci U S A (1992) 1.28
Inactivation of lysis of oncornaviruses by human serum. Virology (1976) 1.26
In vitro construction of a B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses. Proc Natl Acad Sci U S A (1980) 1.25
Primary structure of a human small nuclear ribonucleoprotein polypeptide as deduced by cDNA analysis. J Biol Chem (1989) 1.25
Fibronectin: a chromatin-associated protein? Cell (1979) 1.25
Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis. Diabet Med (2013) 1.23
Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol (1985) 1.20
A murine monoclonal antibody recognizes the 13,000 molecular weight polypeptide of the Sm small nuclear ribonucleoprotein complex. J Immunol (1985) 1.20
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. J Clin Invest (1982) 1.20
Human snRNP polypeptide D1 promotes pre-mRNA splicing in yeast and defines nonessential yeast Smd1p sequences. Nucleic Acids Res (1993) 1.17
Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice. J Exp Med (1981) 1.17
Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci U S A (1983) 1.16
Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces. Proc Natl Acad Sci U S A (1978) 1.16
Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. Proc Natl Acad Sci U S A (1981) 1.13
Highly efficient induction of type C retroviruses by a human tumor in athymic mice. Proc Natl Acad Sci U S A (1980) 1.11
Identification of a major human serum DNA-binding protein as beta 1H of the alternative pathway of complement activation. Biochem Biophys Res Commun (1980) 1.09
Induction of lymphoma in antigenically stimulated athymic mice. Cancer Res (1982) 1.08
Tryptophan synthetase from Bacillus subtilis. Purification and characterization of the component. J Biol Chem (1973) 1.07
Structural analysis of the major envelope glycoprotein (gp70) of the amphotropic and ecotropic type C viruses of wild mice. Virology (1978) 1.06
Induction of sarcomas in athymic mice. Proc Natl Acad Sci U S A (1982) 1.05
HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. AIDS Res Hum Retroviruses (1997) 1.03
Heterologous expression and epitope mapping of a human small nuclear ribonucleoprotein-associated Sm-B'/B autoantigen. J Immunol (1990) 1.02
Proteins of nuclear ribonucleoprotein subcomplexes. Methods Cell Biol (1978) 1.02
Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6. AIDS Res Hum Retroviruses (1992) 1.01
Insertional inactivation of trpC in cloned Bacillus trp segments: evidence for a polar effect on trpF. J Bacteriol (1979) 0.99
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant. J Acquir Immune Defic Syndr (2000) 0.99
Mapping of the immunoreactive domains of a small nuclear ribonucleoprotein-associated Sm-D autoantigen. Clin Immunol Immunopathol (1992) 0.99
Cross-reactivity of the B/B' subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptides. Clin Immunol Immunopathol (1992) 0.99
Alternate sources and substitutes for therapeutic blood components. Blood (1985) 0.99
Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees. Proc Natl Acad Sci U S A (1991) 0.98
Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Meniere's disease. Laryngoscope (1997) 0.97
Unique DNA-binding protein in the serum of patients with various neoplasms. Nature (1975) 0.97
Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells. J Infect Dis (1994) 0.96
Chemical cross-linking of Sm and RNP antigenic proteins. Biochemistry (1988) 0.95
Purification and characterization of two major DNA-binding proteins in human serum. J Biol Chem (1977) 0.95
Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum (1995) 0.94
Characterization of the La (SS-B) antigen from several mammalian sources. J Immunol (1984) 0.94
Disassembly of viral membranes by complement independent of channel formation. Proc Natl Acad Sci U S A (1979) 0.93
B-cell epitopes of Sm autoantigens. Mol Biol Rep (1992) 0.93
Catalytic studies on tryptophanase from Bacillus alvei. J Bacteriol (1973) 0.93
In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune). Clin Diagn Lab Immunol (1998) 0.93
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen. AIDS (2000) 0.92
Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg (1998) 0.91
Serum ribonuclease activity in cancer patients. Br J Cancer (1978) 0.91
Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus. J Clin Invest (1981) 0.90
Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.89
Induction of lymphoma in athymic mice: a model for study of the human disease. Proc Natl Acad Sci U S A (1980) 0.89
Association of an RNA polymerase III transcription factor with a ribonucleoprotein complex recognized by autoimmune sera. Nucleic Acids Res (1984) 0.88
Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system. Clin Immunol Immunopathol (1997) 0.88
Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate. JAMA (1980) 0.88
Thermotropic lipid phase separation in the human immunodeficiency virus. Biochim Biophys Acta (1988) 0.88
T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion. Clin Exp Immunol (1993) 0.87
Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.87
Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum (1997) 0.87
Partial attenuation of the pressor response to endotracheal intubation. A comparison of the effects of intravenous clonidine and fentanyl. Eur J Anaesthesiol (1992) 0.86
DNA-binding proteins in human serum. Biochem Biophys Res Commun (1975) 0.86
Autoimmunity and filariasis. Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis. J Immunol (1993) 0.86
The quantimet cytoscreen and the interactive approach to cancer screening. J Histochem Cytochem (1974) 0.86